• Schedule 13D/G History

Farallon Capital Partners, L.P. - Significant Ownership

Signature - Title
Farallon Capital Partners, L.P. - Hannah E. Dunn, Managing Member of its General Partner
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Farallon Capital Partners, L.P..

Significant Ownership of Farallon Capital Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTGX Protagonist Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 9.99% $356M 5.96M Dapice Joshua J. Dec 31, 2024
SVRA Savara Inc. Common Stock, par value $0.001 per share (the "Shares") 9.99% $50.5M 18.3M Dapice Joshua J. Dec 31, 2024
BEAM Beam Therapeutics Inc. Common Stock, par value $0.01 per share (the "Shares") 9.9% $206M 8.24M Dapice Joshua J. Dec 31, 2024
AGIO AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares") 9.9% $181M 5.67M Dapice Joshua J. Dec 31, 2024
ENTA ENANTA PHARMACEUTICALS INC Common Stock, par value $0.01 per share (the "Shares") 9.9% $16.4M 2.11M Dapice Joshua J. Dec 31, 2024
EXEL EXELIXIS, INC. Common Stock, par value $0.001 per share (the "Shares") 8.4% $64.2M 23.4M Dapice Joshua J. Mar 5, 2025
CATX Lantheus Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 7.6% $1.24M 5.32M Dapice Joshua J. Dec 31, 2024
ELEV Elevation Oncology, Inc. Common Stock, Par Value $0.0001 per share (the "Shares") 6% $1.8M 3.53M Dapice Joshua J. Dec 31, 2024
NYT The New York Times Company Class A Common Stock, par value $0.10 per share (the "Shares") 5.5% $444M 9.01M Dapice Joshua J. Feb 11, 2025
ARMK Aramark Common Stock, Par Value $0.01 per share (the "Shares") 5.1% $487M 13.6M Dapice Joshua J. Feb 11, 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.4% $12.1K 221K Dapice Joshua J. Dec 31, 2024
ANNA AleAnna, Inc. Class A common stock, par value $0.0001 per share (the "Shares") 2.6% $5.47M 1.07M Dapice Joshua J. Dec 31, 2024

Schedules 13D/G Reported by Farallon Capital Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.